The effect of etrasimod on faecal calprotectin and high-sensitivity C-reactive protein: Results from the ELEVATE UC clinical programme

被引：0

作者：

Jairath, V. ^{[1
,2
]}

Rubin, D. T. ^{[3
]}

Verstockt, B. ^{[4
,5
]}

Cekin, A. H. ^{[6
]}

Abreu, M. T. ^{[7
]}

Lees, C. W. ^{[8
,9
]}

Fellmann, M. ^{[10
]}

Woolcott, J. C. ^{[11
]}

Crosby, C. ^{[12
]}

Wu, J. ^{[13
]}

Bhattacharjee, A. ^{[14
]}

Herman, D. ^{[12
]}

Gu, G. ^{[12
]}

Siegmund, B. ^{[15
,16
,17
,18
]}

机构：

[1] Western Univ, Dept Med, London, ON, Canada

[2] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada

[3] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Sect Gastroenterol Hepatol & Nutr, Chicago, IL USA

[4] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium

[5] Katholieke Univ Leuven, Translat Res GI Disorders, Dept Chron Dis & Metab, Leuven, Belgium

[6] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Gastroenterol, Antalya, Turkiye

[7] Univ Miami, Miller Sch Med, Dept Med, Crohns & Colitis Ctr,Div Gastroenterol, Miami, FL 33136 USA

[8] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland

[9] NHS Lothian, Western Gen Hosp, Edinburgh IBD Unit, Edinburgh, Midlothian, Scotland

[10] Pfizer AG, Zurich, Switzerland

[11] Pfizer Inc, Collegeville, PA USA

[12] Pfizer Inc, La Jolla, CA USA

[13] Pfizer Inc, Cambridge, MA USA

[14] Pfizer Healthcare India Pvt Ltd, Chennai, Tamil Nadu, India

[15] Charite Univ Med Berlin, Med Klin Gastroenterol Infektiol Rheumatol, Berlin, Germany

[16] Free Univ Berlin, Berlin, Germany

[17] Humboldt Univ, Berlin, Germany

[18] Campus Benjamin Franklin, Berlin, Germany

来源：

JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P788

引用

页码：I1458 / I1460

页数：3

共 50 条

[21] Physical Activity and High-Sensitivity C-Reactive Protein
Eric P. Plaisance
Peter W. Grandjean
Sports Medicine, 2006, 36 : 443 - 458
[22] Physical activity and high-sensitivity C-reactive protein
Plaisance, Eric P.
Grandjean, Peter W.
SPORTS MEDICINE, 2006, 36 (05) : 443 - 458
[23] A Test in Context High-Sensitivity C-Reactive Protein
Ridker, Paul M.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (06) : 712 - +
[24] High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Young, Ian
Rifai, Nader
CLINICAL CHEMISTRY, 2009, 55 (02) : 201 - 202
[25] Treatment concentration of high-sensitivity C-reactive protein
Michos, Erin D.
Blumenthal, Roger S.
LANCET, 2018, 391 (10118): : 287 - 289
[26] Steatosis DeLIVERs High-Sensitivity C-Reactive Protein
Luyendyk, James P.
Guo, Grace L.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (08) : 1714 - 1715
[27] High-Sensitivity C-Reactive Protein and Risk of Sepsis
Wang, Henry E.
Shapiro, Nathan I.
Safford, Monika M.
Griffin, Russell
Judd, Suzanne
Rodgers, Joel B.
Warnock, David G.
Cushman, Mary
Howard, George
PLOS ONE, 2013, 8 (07):
[28] Comparison of C-Reactive Protein and High-Sensitivity C-Reactive Protein Levels in Patients on Hemodialysis
Helal, Imed
Zerelli, Lilia
Krid, Madiha
ElYounsi, Fethi
Ben Maiz, Hedi
Zouari, Bechir
Adelmoula, Jaouida
Kheder, Adel
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (03) : 477 - 483
[29] Problems with high-sensitivity C-reactive protein - Reply
Ockene, IS
Matthews, CE
Rifai, N
Ridker, PM
Reed, G
Stanek, E
CLINICAL CHEMISTRY, 2003, 49 (01) : 201 - 202
[30] HIGH-SENSITIVITY C-REACTIVE PROTEIN AND RISK OF SEPSIS
Wang, Henry
Shapiro, Nathan
Safford, Monika
Griffin, Russell
Judd, Suzanne
Rodgers, Joel
Warnock, David
Cushman, Mary
Howard, George
CRITICAL CARE MEDICINE, 2012, 40 (12) : U29 - U29

← 1 2 3 4 5 →